Mobile Site ›

Test Catalog

Take Our Survey

Test ID: SLO    
Smith-Lemli-Opitz Screen, Plasma

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Useful For Suggests clinical disorders or settings where the test may be helpful

Diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency)


Smith-Lemli-Opitz syndrome  is a multiple congenital anomaly disorder caused by defective cholesterol biosynthesis due to deficiency of the enzyme 7-dehydrocholesterol reductase.


Clinical variability has been noted, even within families, and the severity of SLOS ranges from severe to mild.


Elevated plasma concentrations of 7-dehydrocholesterol (7-DHC) and 8-dehydrocholesterol (8-DHC) are highly suggestive of a biochemical diagnosis of Smith-Lemli-Opitz syndrome.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Gas Chromatography-Mass Spectrometry (GC-MS)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Smith-Lemli-Opitz Scrn, P

Aliases Lists additional common names for a test, as an aid in searching

7-Dehydrocholesterol Reductase Deficiency
RSH Syndrome
Smith Lemli Opitz (SLO)